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Letters to the Editor
Dear Sir:
A recent review by Dr. Mushak (1) dis-
cusses several of the procedures used to an-
alyze for organic mercurials by gas chroma-
tography. He points out that there are several
problems associated with these procedures,
including halide exchange and decomposition
on-column, and difficulty in unambiguously
identifying the "peak" as being due to the
compound expected. We feel that the techni-
cal problems are more severe even than Dr.
Mushak indicates, and would like to make
available some of our observations.
We have experimented with the FDA pro-
cedure used by Drs. Kamps and Malone [de-
rived from the various modifications of Wes-
t6o's method (2-4)], the method developed
by T. W. Beak Consultants, Ltd. (5), and a
procedure recommended to us by Dr. Mushak
(6). Our instrumentation was basically the
same as that described by Baughman et al.
(7).
The major problems we encountered in
methylmercury analysis seemed to fall under
four categories: recovery, GLC liquid phases,
injection techniques, and detection. Most of
the published methods assume either that
recovery of CH,Hg from water is quantita-
tively comparable to recovery from a tissue
homogenate, or that recovery of CH3Hg from
tissue homogenates is independent of the
ratio of mercury to protein. In brief, both
assumptions are incorrect. First, the recov-
ery of CH,Hg from water is commonly less
than that from tissue homogenates, possibly
because of the almost instantaneous loss of
CH,Hg from dilute aqueous solutions (8) in
the absence of protecting agents.
We find the recovery of CH.HgCl spikes
from liver to fall on one recovery curve when
the mercury concentration is >50 ppm, and
another when the concentration is <50 ppm.
The recovery from kidney was different from
the recovery from liver at similar spiking
levels. These variations were not seen with
the FDA procedure (which uses large vol-
umes, and huge excesses of extracting re-
agents), but this procedure assumes that re-
covery from water equals recovery from
homogenates, which we could not confirm.
The FDA procedure uses phenyldiethanol-
amine succinate as a liquid phase. In our
hands, water eluted from this packing at the
same position as methylmercury chloride,
the mercurial eluted before the electron
capture detector had recovered from the sol-
vent surge, and both effects made quantita-
tion nearly impossible. The column packing
recommended by T. W. Beak Consultants,
Ltd., 7% Carbowax 20M on Varaport 30, had
a very short usable lifetime (2-3 months),
but worse, required that several injections
of stock CH,HgCl be made daily until the
response reached a stable maximum. This
resulted in the appearance of "ghost" peaks
from blank injections. We tested two batches
of Durapak Carbowax 400 on Porasil as rec-
ommended by Dr. Mushak. One batch per-
formed as reported (1), while no methyl-
mercury elution could be detected from the
other. Only the former was specifically "low
K."
Finally, since glass columns and on-column
injection are necessary to avoid reaction of
the mercurial with metal parts in the injec-
tion port, we had problems with decomposi-
tion of the liquid phases at the ends of the
columns in contact with the injector and
detector blocks. The addition of HgCl. to
homogenates a:) recommended by West66
gives a "ghost" peak in blanks if carboniza-
tion has occurred at the front of the GLC
column.
We found it necessary to pull enough sol-
vent (benzene or acetone) into the syringe
ahead of the CH3HgCl solutions to ensure
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of the needle. If this is not done, continued
use of a particular syringe results in artifact
peaks from methylmercury incapable of being
washed out of the (stainless steel) needle but
capable of being volatized out in the hot in-
jection port.
The electron capture detector responds to
the halide atom associated with methyl mer-
cury. Although Baughman et al. (7) have
demonstrated that methylmercury elutes as a
mixture of chloride, bromide, and iodine if
the three halides have ever had the oppor-
tunity to encounter the column packing, it
would not appear to have been specifically
pointed out that the detector will not be
equally sensitive to the three halides. This
phenomenon may account for much of the ap-
parent day-to-day variations in detector sen-
sitivity to methylmercury.
Those details of technique that have proven
successful in overcoming the above problems
in our laboratory are as follows. First, we use
a column packing of 12%7 diethylene glycol
succinate on HCl-washed Chromosorb W and
never inject solutions containing halides
other than chloride. We pack the front and
back 4 in. of the column with 3%
OV-1 on acid-washed Chromosorb W to elim-
inate decomposition in the heated blocks.
We avoid extraction methods that require
the use of iodide or bromide.
To cope with the recovery problems, we
spike all samples with ethylmercury chloride
before extracting, and then add 2,2'-dichloro-
biphenyl to the final solution just prior to
GLC. This procedure compensates for day-
to-day variations in detector sensitivity, and
gives a built-in measure of recovery of mer-
curial. Statistical analyses confirmed the con-
siderable improvement in reproducibility and
precision that these modifications made com-
pared to use of recovery curves drawn for
spiked (CH:Hg) smples.
Phillip W. Albro and Ann D. Latimer
NIEHS
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